Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sc…
$2.93+2.45%
报价 2026-11-13
市值
$139.1M
EV
$155.3M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -63.6%
$2.42$8.06
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| QTRXQuanterix Corporation | $139.1M | +2.4% | +27.6% | 41.7% | – | – | – | |
| SGHTSight Sciences, Inc. | $601.9M | -1.5% | +19.1% | 88% | – | – | – | |
| SENSSenseonics Holdings, Inc. | $579.6M | +5.4% | +92.0% | 58.7% | – | – | – | 高增长 |
| MASS908 Devices Inc. | $405M | -0.5% | +26.7% | 49.8% | – | – | 911.9x | |
| VMDViemed Healthcare, Inc. | $347.5M | +0.7% | +16.8% | 57% | 23.4x | 6.9x | 16.3x | GARP |
| IMRXImmuneering Corporation | $240.3M | +1.1% | +1836.4% | 0% | – | – | – | |
| INGNInogen, Inc. | $148M | +1.2% | +4.9% | 48.9% | – | – | – | |
| OMOutset Medical, Inc. | $70.3M | -3.4% | +8.0% | 41.8% | – | – | – | |
| NNOXNano-X Imaging Ltd. | $25.4M | +1.2% | – | -338.2% | – | – | – | |
| 同行中位数 | – | – | +19.1% | 49.3% | 23.4x | 6.9x | 464.1x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。